This page shows All For One Medi (AFOM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
All For One Medi passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, All For One Medi generates $-0.27 in operating cash flow (-$497K OCF vs $1.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
All For One Medi earns $-0.3 in operating income for every $1 of interest expense (-$525K vs $1.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
All For One Medi generated $9K in revenue in fiscal year 2022. This represents a decrease of 5.3% from the prior year.
All For One Medi reported $1.8M in net income in fiscal year 2022. This represents an increase of 158.9% from the prior year.
Cash & Balance Sheet
All For One Medi held $99K in cash against $0 in long-term debt as of fiscal year 2022.
All For One Medi had 8.04B shares outstanding in fiscal year 2022. This represents an increase of 91.8% from the prior year.
Margins & Returns
All For One Medi's operating margin was -5836.4% in fiscal year 2022, reflecting core business profitability. This is up 583.6 percentage points from the prior year.
All For One Medi's net profit margin was 20410.3% in fiscal year 2022, showing the share of revenue converted to profit. This is up 53228.9 percentage points from the prior year.
Capital Allocation
AFOM Income Statement
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3K+25.1% | $2K-14.8% | $2K+6.0% | $2K-30.1% | $3K+177.3% | $1K-49.4% | $2K-2.7% | $2K |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $14K-4.2% | $14K-62.3% | $38K-7.0% | $41K+47.9% | $28K-65.9% | $81K-12.5% | $92K-35.7% | $144K |
| Operating Income | -$48K+30.7% | -$69K+44.8% | -$125K-28.2% | -$97K-19.2% | -$82K+46.5% | -$153K+21.0% | -$193K+16.4% | -$231K |
| Interest Expense | $165K-5.4% | $175K-23.1% | $227K-22.6% | $294K-6.8% | $315K-44.0% | $562K+27.2% | $442K-20.4% | $555K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Net Income | -$91K+91.9% | -$1.1M-248.3% | $757K+116.4% | -$4.6M-200.0% | $4.6M+231.3% | -$3.5M-165.6% | $5.3M+214.3% | -$4.7M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A |
AFOM Balance Sheet
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8K-79.5% | $37K+69.8% | $22K-79.2% | $105K+147.8% | $43K-14.3% | $50K-66.2% | $147K+19.8% | $123K |
| Current Assets | $8K-79.5% | $37K+69.8% | $22K-79.2% | $105K+190.5% | $36K-26.9% | $50K-66.2% | $147K+19.8% | $123K |
| Cash & Equivalents | $2K-70.4% | $6K-60.9% | $15K-84.4% | $99K+367.0% | $21K-27.5% | $29K-74.3% | $114K+12.0% | $101K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $15.7M+0.2% | $15.6M+7.7% | $14.5M-5.8% | $15.4M+37.0% | $11.3M-30.1% | $16.1M+24.5% | $12.9M-29.1% | $18.2M |
| Current Liabilities | $15.9M+0.2% | $15.9M+7.5% | $14.8M-5.7% | $15.7M | N/A | N/A | N/A | $18.6M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$15.7M-0.3% | -$15.6M-7.6% | -$14.5M+5.3% | -$15.3M-36.6% | -$11.2M+30.1% | -$16.1M-25.5% | -$12.8M+29.4% | -$18.1M |
| Retained Earnings | -$26.2M-0.3% | -$26.1M-4.5% | -$24.9M+3.0% | -$25.7M-21.7% | -$21.1M+17.9% | -$25.7M-15.7% | -$22.2M+19.4% | -$27.6M |
AFOM Cash Flow Statement
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$10K+47.2% | -$19K+76.7% | -$83K+14.6% | -$98K-84.7% | -$53K+60.8% | -$134K+36.5% | -$212K+8.2% | -$231K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $0 | N/A | N/A | N/A | $0 |
| Financing Cash Flow | $6K-40.0% | $10K | $0-100.0% | $175K+234.9% | $52K+4.5% | $50K-77.7% | $224K-8.2% | $244K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
AFOM Financial Ratios
| Metric | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -1863.4%+1499.9pp | -3363.3%+1829.4pp | -5192.7%-900.1pp | -4292.5%-1776.6pp | -2516.0%+10531.4pp | -13047.4%-4688.9pp | -8358.5%+1366.7pp | -9725.2% |
| Net Margin | -3540.5%+51323.6pp | -54864.1%-86393.4pp | 31529.3%+234774.9pp | -203245.6%-345224.3pp | 141978.7%+441726.1pp | -299747.4%-530715.8pp | 230968.4%+427670.2pp | -196701.8% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -1186.0%+1831.9pp | -3018.0%-6474.0pp | 3456.1%+7822.6pp | -4366.5%-15188.4pp | 10821.9%+17882.8pp | -7061.0%-10696.1pp | 3635.2%+7448.2pp | -3813.0% |
| Current Ratio | 0.000.0 | 0.000.0 | 0.000.0 | 0.01 | N/A | N/A | N/A | 0.01 |
| Debt-to-Equity | -1.000.0 | -1.000.0 | -1.000.0 | -1.010.0 | -1.000.0 | -1.000.0 | -1.010.0 | -1.01 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$15.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is All For One Medi's annual revenue?
All For One Medi (AFOM) reported $9K in total revenue for fiscal year 2022. This represents a -5.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is All For One Medi's revenue growing?
All For One Medi (AFOM) revenue declined by 5.3% year-over-year, from $9K to $9K in fiscal year 2022.
Is All For One Medi profitable?
Yes, All For One Medi (AFOM) reported a net income of $1.8M in fiscal year 2022, with a net profit margin of 20410.3%.
What is All For One Medi's operating margin?
All For One Medi (AFOM) had an operating margin of -5836.4% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.
What is All For One Medi's net profit margin?
All For One Medi (AFOM) had a net profit margin of 20410.3% in fiscal year 2022, representing the share of revenue converted into profit after all expenses.
What is All For One Medi's operating cash flow?
All For One Medi (AFOM) generated -$497K in operating cash flow during fiscal year 2022, representing cash generated from core business activities.
What are All For One Medi's total assets?
All For One Medi (AFOM) had $105K in total assets as of fiscal year 2022, including both current and long-term assets.
What is All For One Medi's current ratio?
All For One Medi (AFOM) had a current ratio of 0.01 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.
What is All For One Medi's debt-to-equity ratio?
All For One Medi (AFOM) had a debt-to-equity ratio of -1.01 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is All For One Medi's return on assets (ROA)?
All For One Medi (AFOM) had a return on assets of 1740.2% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is All For One Medi's cash runway?
Based on fiscal year 2022 data, All For One Medi (AFOM) had $99K in cash against an annual operating cash burn of $497K. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is All For One Medi's debt-to-equity ratio negative or unusual?
All For One Medi (AFOM) has negative shareholder equity of -$15.3M as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is All For One Medi's Piotroski F-Score?
All For One Medi (AFOM) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are All For One Medi's earnings high quality?
All For One Medi (AFOM) has an earnings quality ratio of -0.27x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can All For One Medi cover its interest payments?
All For One Medi (AFOM) has an interest coverage ratio of -0.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.